Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fluoroquinolones, 10 years later]

A de la Blanchardière1, C Carbon

  • 1Service de médecine interne, CHU Bichat-Claude-Bernard, Paris.

La Revue Du Praticien
|September 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The appropriateness of antibiotic prescriptions for positive urine cultures in hospitalized adult patients: A French multicenter prospective study.

Infectious diseases now·2025
Same author

[Predatory journals: A real threat for medical research. 1. Identify these journals and understand how they work].

La Revue de medecine interne·2021
Same author

[Predatory journals: A real threat for medical research. 2 Assess their consequences and initiate a response].

La Revue de medecine interne·2021
Same author

Rothia spp. infective endocarditis: A systematic literature review.

Infectious diseases now·2020
Same author

Effect of a prospective audit with intervention and feedback on Clostridioides difficile infection management.

International journal of clinical pharmacy·2020
Same author

[Scientific misconduct: A major threat for medical research].

La Revue de medecine interne·2020

Fluoroquinolone antibiotics face resistance, limiting use for common infections. Future research focuses on new compounds targeting resistant bacteria, intracellular pathogens, and parasites.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • The fluoroquinolone antibiotic class has undergone significant changes due to evolving bacterial resistance patterns.
  • Increasing resistance in staphylococci and Gram-negative bacteria has restricted their use in nosocomial infections.
  • Limitations in antibacterial spectrum affect efficacy against certain respiratory pathogens like pneumococci and streptococci.

Purpose:

  • To review the current landscape and future directions of fluoroquinolone antibiotics.
  • To highlight the impact of antimicrobial resistance on fluoroquinolone utility.
  • To identify areas for development of novel fluoroquinolone compounds.

Summary:

  • Fluoroquinolone use is now primarily for specific community-acquired infections due to resistance.

Related Experiment Videos

  • Their effectiveness against respiratory infections is reduced due to spectrum limitations.
  • New fluoroquinolone developments aim for broader activity, including against Gram-positive cocci, intracellular bacteria (e.g., mycobacteria), and parasites.

    • Impact:

    • Understanding these shifts is crucial for managing antibiotic resistance and guiding future drug development.
    • Clinical trials for new fluoroquinolone compounds must address tolerance issues.
    • The evolution of fluoroquinolones impacts treatment strategies for various infectious diseases.